<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2025.1650340</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Decoding the regulatory networks of <italic>Proteus mirabilis</italic> under succinic acid stress: a multi-omics approach</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Yang</surname>
<given-names>Aoyu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2881724/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Cai</surname>
<given-names>Yuqing</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Zhang</surname>
<given-names>Ziyi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2755872/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Yafang</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shen</surname>
<given-names>Chen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1545157/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Wei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1548546/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>You</surname>
<given-names>Haiqing</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Sha</surname>
<given-names>Shanshan</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1856239/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Li</surname>
<given-names>Huajun</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/887036/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Li</surname>
<given-names>Xiancheng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2779202/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Urology, The Second Affiliated Hospital of Dalian Medical University</institution>, <addr-line>Dalian</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Microecology, College of Basic Medical Sciences, Dalian Medical University</institution>, <addr-line>Dalian</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Microbiology, Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Dalian Medical University</institution>, <addr-line>Dalian</addr-line>,&#xa0;<country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/190778/overview">Michael Marceau</ext-link>, Universit&#xe9; Lille Nord de France, France</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1652766/overview">Dawid Gmiter</ext-link>, Jan Kochanowski University in Kielce, Poland</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2384227/overview">Ghassan Ghssein</ext-link>, Islamic University of Lebanon, Lebanon</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Xiancheng Li, <email xlink:href="mailto:lixiancheng@dmu.edu.cn">lixiancheng@dmu.edu.cn</email>; Huajun Li, <email xlink:href="mailto:lhjcmu@hotmail.com">lhjcmu@hotmail.com</email>; Shanshan Sha, <email xlink:href="mailto:shanshan_sha@dmu.edu.cn">shanshan_sha@dmu.edu.cn</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>03</day>
<month>10</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>15</volume>
<elocation-id>1650340</elocation-id>
<history>
<date date-type="received">
<day>03</day>
<month>07</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>09</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Yang, Cai, Zhang, Xu, Shen, Wang, You, Sha, Li and Li.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Yang, Cai, Zhang, Xu, Shen, Wang, You, Sha, Li and Li</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>
<italic>Proteus mirabilis</italic>, a major catheter-associated urinary tract infection pathogen, forms antibiotic-resistant crystalline biofilms. Our study demonstrates succinic acid&#x2019;s multimodal inhibition of <italic>P.mirabilis</italic> via multi-omics analyses. At 15 mM, succinic acid reduced bacterial growth (&#x2265;70%) and biofilm formation (&#x2265;50%). Metabolomics revealed that succinic acid treatment induces dysregulation in the tryptophan and arginine metabolism, nucleotide biosynthesis, and tricarboxylic acid cycle in <italic>P.mirabilis</italic>. Transcriptomics revealed downregulated ribosomal genes, oxidative phosphorylation, and efflux pumps, alongside upregulated arginine transport. Proteomics showed suppression of T6SS virulence factors and iron acquisition proteins. We propose that succinic acid reduces K6 acetylation of the histone-like nucleoid structuring protein, enhancing its oligomerization to repress T6SS genes and inhibit biofilm formation. By targeting metabolism, virulence, and stress adaptation, succinic acid circumvents single-target resistance, offering a strategy to combat multidrug-resistant <italic>P.mirabilis</italic> through biofilm disruption and pathogenicity suppression.</p>
</abstract>
<kwd-group>
<kwd>multi-omics</kwd>
<kwd>succinic acid</kwd>
<kwd>biofilm formation</kwd>
<kwd>proteus mirabilis</kwd>
<kwd>urinary tract infection</kwd>
</kwd-group>
<contract-sponsor id="cn001">Department of Education of Liaoning Province<named-content content-type="fundref-id">10.13039/501100007620</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Department of Science and Technology of Liaoning Province<named-content content-type="fundref-id">10.13039/501100012131</named-content>
</contract-sponsor>
<counts>
<fig-count count="7"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="64"/>
<page-count count="14"/>
<word-count count="6707"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Molecular Bacterial Pathogenesis</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>
<italic>Proteus mirabilis</italic>, a Gram-negative bacillus, represents one of the most prevalent pathogens in catheter-associated urinary tract infections (CAUTIs), ranking immediately after <italic>Escherichia coli</italic> and <italic>Klebsiella pneumoniae</italic> in frequency (<xref ref-type="bibr" rid="B50">Sokhn et&#xa0;al., 2020</xref>), particularly among elderly patients (<xref ref-type="bibr" rid="B13">Chakkour et&#xa0;al., 2024</xref>), and constitutes the predominant causative agent (10%-44%) in double-J stent-associated urinary tract infections (DJUTIs) (<xref ref-type="bibr" rid="B27">Hunt et&#xa0;al., 2024</xref>). The pathogenicity of this organism relies on multiple virulence factors, including urease production, adhesins expression, and flagellar motility (<xref ref-type="bibr" rid="B63">Yang et&#xa0;al., 2024</xref>). Distinct from other CAUTI pathogens, <italic>P.mirabilis</italic>-induced infections frequently promote urinary calculus formation through urease-mediated urea hydrolysis. This process generates ammonia that elevates urinary pH, facilitating crystal nucleation and growth, thereby exacerbating infection complexity and therapeutic resistance. Furthermore, this organism forms crystalized biofilms through secretion of extracellular polymers (e.g., polysaccharides, proteins), creating mineral-organic composite structures (<xref ref-type="bibr" rid="B6">Awonusi et&#xa0;al., 2022</xref>). In clinical practice, indwelling double-J (D-J) stents (retention period: 2 weeks to 1 year) (<xref ref-type="bibr" rid="B56">Wang et&#xa0;al., 2023</xref>) provide optimal surfaces for bacterial adhesion and colonization in ureteral obstruction patients. The crystalized biofilms of <italic>P.mirabilis</italic> not only confer resistance to antibiotics and host immune defenses, but also induce stent encrustation and infectious stone formation (<xref ref-type="bibr" rid="B12">Caldara et&#xa0;al., 2025</xref>) (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). Biofilm-mediated urinary tract infections demonstrate high recurrence rates and elevate risks of ureteral injury, drainage dysfunction, and renal failure (<xref ref-type="bibr" rid="B47">Prywer et&#xa0;al., 2023</xref>). Therefore, inhibiting crystalized biofilm formation constitutes a critical strategy for preventing and managing these infections.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>The crystallization biofilm formation process of <italic>P.mirabilis</italic> on ureteral stent surfaces progresses through three distinct phases. Following initial colonization mediated by fimbrial adhesins, quorum sensing-regulated swarming motility is initiated to promote bacterial aggregation and proliferation. Concurrently, urease-mediated urea hydrolysis elevates microenvironmental pH, accelerating mineral crystallization and deposition. These coordinated biological processes ultimately culminate in the development of mature crystal-embedded biofilm.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1650340-g001.tif">
<alt-text content-type="machine-generated">Illustration of biofilm formation on a D-J ureteral stent surface, showing stages of attachment, swarming motility, and biofilm maturation and detachment. The biofilm contains bacterial cells and components like urinary crystals, DNA chains, and mucopolysaccharide chains. A pH scale is displayed on the side.</alt-text>
</graphic>
</fig>
<p>However, the persistent nature of established biofilms poses significant therapeutic challenges. Studies have demonstrated that traditional antibiotics exhibit poor penetrability through <italic>P.mirabilis</italic> biofilms due to extracellular polymeric substances (EPS) entrapment, the biofilm matrix restricts antibiotic diffusion via physical barriers and reduces antimicrobial susceptibility by inducing bacterial metabolic dormancy (<xref ref-type="bibr" rid="B31">Lebeaux et&#xa0;al., 2014</xref>). Although current therapies attempt biofilm prevention through early-stage interventions like silver-ion coatings and antibiotic-impregnated catheters (<xref ref-type="bibr" rid="B28">Jacobsen and Shirtliff, 2011</xref>), their efficacy remains limited by low silver elution rates and protective crystal layer formation on catheter surfaces. These limitations underscore the critical need for novel biofilm inhibitors targeting <italic>P.mirabilis</italic> in CAUTI management. The development of non-antibiotic antimicrobial agents with specific antibiofilm properties has become an urgent research priority. Compounding this challenge, the escalating antimicrobial resistance in <italic>P.mirabilis</italic> has reached alarming proportions. This pathogen demonstrates heterogeneous resistance profiles across multiple drug classes, significantly complicating clinical treatment strategies. In recent years, an increasing number of studies have documented the emergence of carbapenem-resistant <italic>P.mirabilis (</italic>
<xref ref-type="bibr" rid="B8">Bedeni&#x107; et&#xa0;al., 2025</xref>). Carbapenems as a critical last-line treatment option for severe bacterial infections, the occurrence of infections caused by carbapenem-resistant <italic>Enterobacterales</italic> poses a significant clinical challenge, often resulting in limited therapeutic options and high mortality rates (<xref ref-type="bibr" rid="B7">Bassetti et&#xa0;al., 2025</xref>). The overuse of antibiotics further exacerbate the development of antimicrobial resistance. Therefore, the identification and development of novel antimicrobial agents with mechanisms of action distinct from those of conventional antibiotics are important for both mitigating the emergence of resistant pathogens and providing effective treatment options against multidrug-resistant infections.</p>
<p>Succinic acid, an organic acid serving as a crucial metabolite in both host organisms and microbial processes, has recently garnered attention for its antimicrobial properties. The antimicrobial mechanism of organic acids involves membrane penetration followed by intracellular dissociation into anions and protons. Proton accumulation induces cytoplasmic acidification, while anion accumulation disrupts metabolic functions, increases osmotic pressure, and ultimately leads to bacterial cell death (<xref ref-type="bibr" rid="B1">Alakomi et&#xa0;al., 2000</xref>).</p>
<p>Investigations into uropathogens have revealed that organic acids from <italic>Lactobacillus</italic> strains exhibit antimicrobial activity against <italic>P.mirabilis (</italic>
<xref ref-type="bibr" rid="B53">Szczerbiec et&#xa0;al., 2023</xref>). Notably, succinic acid demonstrates significant growth inhibition and biofilm suppression across all tested <italic>P.mirabilis</italic> clinical isolates. Propidium iodide (PI) staining assays confirmed membrane integrity disruption in <italic>P.mirabilis</italic> following succinic acid treatment. This fluorescent DNA-intercalating agent penetrates compromised membranes, verifying the compound&#x2019;s membrane-damaging effects (<xref ref-type="bibr" rid="B52">Szczerbiec et&#xa0;al., 2022</xref>). Mechanistic studies in <italic>Microcystis aeruginosa</italic> reveal that succinic acid alters membrane permeability through lipid composition modulation. Concurrent metabolic perturbations include: amino acid metabolism inhibition, nucleotide biosynthesis suppression, tricarboxylic acid (TCA) cycle interference, and nitrogen assimilation impairment, ultimately inducing oxidative damage (<xref ref-type="bibr" rid="B14">Chen et&#xa0;al., 2022</xref>). These findings suggest a multi-target antimicrobial mechanism involving microbial metabolic network disruption. Despite these evidences of bactericidal and antibiofilm activities against <italic>P.mirabilis</italic>, the precise molecular targets and detailed mechanism of action remain elusive. Therefore, this study employs multi-omics parallel analysis (metabolomics, transcriptomics and proteomics) to systematically elucidate key pathways and regulatory networks underlying succinic acid&#x2019;s inhibitory effects on <italic>P.mirabilis</italic>, ultimately deciphering its molecular mechanism (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>The flowchart of this study. In our study, Proteus mirabilis was treated with different concentrations of succinic acid under 37&#xa0;&#xb0;C culture conditions. Subsequently, multi-omics analysis was performed on the treated bacterial samples and the control group to systematically elucidate the molecular mechanism by which succinic acid inhibits P. mirabilis.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1650340-g002.tif">
<alt-text content-type="machine-generated">Illustration of a biological study workflow, starting with bacteria and flasks cultured at 37&#xb0;C with succinic acid. It includes colorimetric assay plates and bar graphs showing succinic acid concentration effects. Samples undergo transcriptomic, metabolomic, and proteomic analyses depicted with graphs, Venn diagrams, heat maps, and scatter plots. Equipment like mass spectrometry and a computer with a heat map interface represent analysis stages.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s2">
<title>Methods</title>
<sec id="s2_1">
<title>Reagents and strains</title>
<p>Succinic acid and all culture reagents, including Tryptic Soy Broth (TSB), agar, Phosphate-Buffered Saline (PBS), methanol, ethanol, and crystal violet, were procured from Dalian Amioke Biological Technology Co., Ltd. Sterile succinic acid solutions (5, 10, 15, 20, 50 mM) were prepared in triple-distilled H2O, sterilized through 0.22 &#x3bc;m membrane filtration, and stored at 4&#xb0;C. The <italic>P.mirabilis</italic> reference strain ATCC<sup>&#xae;</sup> 29906 was cultured on Tryptic Soy Agar (TSA) plates from -80&#xb0;C glycerol stock. Single colonies were inoculated into TSB medium and incubated at 37&#xb0;C with 180 rpm agitation to achieve logarithmic growth phase (OD550&#xa0;=&#xa0;0.1, 8&#xd7;10<sup>8</sup> CFU/mL) for subsequent experiments.</p>
</sec>
<sec id="s2_2">
<title>Measurement of minimum inhibitory concentration and minimum biofilm inhibitory concentration</title>
<p>The minimum inhibitory concentration was determined using broth microdilution method (<xref ref-type="bibr" rid="B40">Manoharan et&#xa0;al., 2020</xref>), defined as the lowest concentration inhibiting &#x2265;70% bacterial growth compared to untreated controls. For the biofilm inhibition assay, succinic acid powder was dissolved in triple-distilled H2O to prepare a filter-sterilized 100 mM stock solution. This stock was then serially diluted to create working solutions at 10, 20, 30, 40, and 100 mM. In the assay, 100 &#x3bc;L of each working solution was added to 100 &#x3bc;L of bacterial suspension in a 96-well plate (n=6), resulting in final succinic acid concentrations of 5, 10, 15, 20, and 50 mM, respectively, after equal volume mixing. Control wells received 100 &#x3bc;L of bacterial suspension mixed with an equal volume (100 &#x3bc;L) of triple-distilled H<sub>2</sub>O. Following 48-hour biofilm formation at 37&#xb0;C, planktonic cells were removed by triple PBS washing. Biofilms were methanol-fixed (200 &#x3bc;L, 30&#xa0;min), stained with 0.1% crystal violet (200 &#x3bc;L, 20&#xa0;min), and destained with absolute ethanol (200 &#x3bc;L). Absorbance at 550 nm was measured spectrophotometrically, with MBIC defined as the concentration achieving &#x2265;50% inhibition calculated by: Inhibition rate (%) = [1 - (OD550 treatment/OD550 control)] &#xd7; 100%. Independent samples t-test was used to compare differences between every two groups for continuous data. Data analysis was performed using SPSS 25.0, and bar graphs were generated using GraphPad Prism 9.5.1.</p>
</sec>
<sec id="s2_3">
<title>Metabolomics analysis</title>
<p>Single colonies of Proteus mirabilis from Tryptic Soy Agar (TSA) plates were inoculated into Tryptic Soy Broth (TSB) and incubated overnight at 37&#xb0;C. This process was repeated independently to generate three separate biological cultures. Bacterial suspensions were centrifuged at 6,000&#xd7;g for 15&#xa0;min at 4&#xb0;C, then resuspended in fresh TSB to an optical density at 550 nm (OD<sub>550</sub>) of 0.1 for subsequent experiments. For treatment groups, 7.5 mL of bacterial suspension from each independent culture was mixed with an equal volume of a filter-sterilized succinic acid solution to achieve a final treatment concentration equivalent to the predetermined 15 mM. The mixtures were incubated statically at 37&#xb0;C for 24&#xa0;h. Control groups received 7.5 mL of bacterial suspension from each independent culture mixed with an equivalent volume of sterile triple-distilled H<sub>2</sub>O. This resulted in three biologically independent replicates for both the treatment and control groups. Post-incubation, all samples were centrifuged (6,000&#xd7;g, 15&#xa0;min, 4&#xb0;C). The resulting cell pellets were washed once with cold PBS, immediately flash-frozen in liquid nitrogen, and stored at -80&#xb0;C until metabolomic analysis. The same sample preparation procedure was followed for all subsequent omics analyses. Metabolomic profiling was performed using Thermo Fisher Scientific&#x2019;s UHPLC-Q Exactive HF-X system. Liquid chromatography separation was achieved with a C18 column (2.1&#xd7;100 mm, 1.7 &#x3bc;m) maintained at 40&#xb0;C. Raw LC-MS data were processed through Progenesis QI software (v2.3, Waters) for baseline correction, peak detection, retention time alignment, and generation of an m/z-retention time-intensity matrix. Metabolite identification was achieved by matching MS/MS spectra against HMDB (v5.0) and METLIN (v2023) databases. Data preprocessing involved removing features with &gt;20% missing values across sample groups, imputing remaining missing values with 10% of the minimum observed intensity, and applying total ion current normalization. Quality control filtering excluded variables exhibiting &gt;30% RSD in QC samples, followed by log10 transformation. Multivariate analysis using the ropls package (v1.6.2) in R included PCA for data structure visualization and OPLS-DA with 7-fold cross-validation to assess model robustness. Significantly altered metabolites were selected based on variable importance in projection (VIP) scores &gt;1.0 and Welch&#x2019;s t-test p value &lt;0.05 after Benjamini-Hochberg correction. KEGG pathway annotation (Release 107.0) and hypergeometric enrichment analysis via scipy.stats (v1.11.1) identified biologically relevant pathways, with statistical significance determined by Fisher&#x2019;s exact test followed by false discovery rate (FDR) adjustment (q&lt;0.05).</p>
</sec>
<sec id="s2_4">
<title>Transcriptomics analysis</title>
<p>High-quality RNA samples were obtained by extracting RNA from single bacteria and removing genomic DNA using the CTAB method. The rRNA was removed using the RiboCop rRNA Depletion Kit. The mRNA was randomly cleaved into small fragments of 200bp, and reverse transcription was performed using the mRNA as a template to synthesize double-stranded cDNA. When synthesizing the second strand, dUTP was used instead of dTTP. The repaired cDNA was added to the junction, and finally the second strand containing dUTP was removed with UNG enzyme. The library was established using Illumina Stranded mRNA Prep, and double-ended RNA-seq sequencing was performed using NovaSeq&#x2122; X Plus. Bioinformatics analysis processes the data generated by the Illumina platform. The gene expression levels were measured using the FPKM and TPM methods. FPKM was calculated based on the number of reads per thousand bases in every million sequences, while TPM was based on the number of reads from a specific transcription per million reads. FPKM and TPM can eliminate the influence of gene length and sequencing depth, thereby enabling the gene expression level to be used for comparison of differences between samples. Differential expression analysis was conducted by obtaining the Read Counts of genes to identify differentially expressed genes and study their functions. The experiment consisted of three biological replicates, and the difference analysis was conducted using DESeq2 software. This analysis was conducted using the software Goatools for enrichment analysis, and the method employed was Fisher&#x2019;s exact test. To control the calculated false positive rate, four multiple test methods (Bonferroni, Holm, Sidak and false discovery rate) were used to correct the p value. Generally, when the p value was &lt;0.05, it was considered that there was a significant enrichment of this KEGG function.</p>
</sec>
<sec id="s2_5">
<title>Proteomics analysis</title>
<p>Frozen samples were retrieved from -80&#xb0;C storage and lysed by ultrasonication in ice-cold lysis buffer (8 M urea, 1% protease inhibitor, 3 &#x3bc;M TSA, 50 mM NAM). After centrifugation (12,000 g, 10&#xa0;min, 4&#xb0;C), the resulting supernatant was collected for protein quantification using the BCA assay. Equal protein aliquots were precipitated with TCA, washed with acetone, and resuspended in 200 mM TEAB for tryptic digestion (1:50, m/m, overnight). Subsequently, peptides underwent reduction (5 mM DTT, 56&#xb0;C, 30&#xa0;min) and alkylation (11 mM IAA, room temperature, 15&#xa0;min in darkness). Peptide separation was achieved via nanoflow liquid chromatography (NanoElute system) using mobile phase A (0.1% formic acid, 2% acetonitrile in water) and phase B (0.1% formic acid in acetonitrile-water) with a gradient elution (6%-80% B over 20&#xa0;min, 500 nl/min). Mass spectrometric analysis was conducted on a timsTOF Pro 2 system (ion source voltage: 1.75 kV) in dia-PASEF mode, with MS1 (300&#x2013;1500 m/z) and MS2 (400&#x2013;850 m/z) scans at a 7 m/z window width. Protein identification and pathway annotation were performed against the KEGG database using blastp (e-value &#x2264; 1e-4), retaining the highest-scoring match for each protein.</p>
</sec>
<sec id="s2_6">
<title>Acetylation omics analysis</title>
<p>Frozen specimens were retrieved from -80&#xb0;C storage and homogenized in lysis buffer (8 M urea, 1% protease inhibitor cocktail, 3 &#x3bc;M TSA, 50 mM NAM) using ultrasonication. After centrifugation, the supernatant was collected for protein quantification. Equal protein aliquots were precipitated with TCA, washed with acetone, and reconstituted in 200 mM TEAB for tryptic digestion (1:50, m/m, overnight at 37&#xb0;C). Digested peptides underwent sequential treatment with 5 mM DTT (56&#xa0;&#xb0;C, 30&#xa0;min) and 11 mM IAA (room temperature, 15&#xa0;min in darkness). The peptides were then dissolved in IP buffer (100 mM NaCl, 1 mM EDTA, 50 mM Tris-HCl, 0.5% NP-40, pH 8.0) and incubated with anti-acetyllysine antibody-conjugated beads (PTM0104) at 4&#xb0;C overnight. After extensive washing, bound peptides were eluted with 0.1% trifluoroacetic acid and desalted using C18 ZipTips prior to LC-MS/MS analysis.</p>
</sec>
<sec id="s2_7">
<title>Molecular modeling</title>
<p>Protein structure prediction was performed using SWISS-MODEL, an automated web-based homology modeling system. The target protein sequence was obtained from the UniProt database, followed by template identification from experimentally determined protein structures. Three-dimensional models were generated through sequence alignment and evaluated based on template identity, amino acid number, and QMEAN score (<xref ref-type="bibr" rid="B44">Patel et&#xa0;al., 2021</xref>). The functional domain containing the K6 site was annotated using PyMOL.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Result</title>
<sec id="s3_1">
<title>Determination of succinic acid&#x2019;s MIC and MBIC against <italic>P.mirabilis</italic>
</title>
<p>The inhibitory effects of succinic acid on <italic>P.mirabilis</italic> are shown in <xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3A and B</bold>
</xref>. In the MIC assay (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>), bacterial growth inhibition significantly increased with rising succinic acid concentrations. The most pronounced inhibitory effect (P &lt; 0.001) was observed at 15 mM, which represented the lowest concentration achieving &#x2265;70% growth inhibition compared to the untreated control, thus establishing 15 mM as the MIC against <italic>P.mirabilis</italic>.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Determination of minimum inhibitory concentration and minimum biofilm inhibitory concentration. <bold>(A, B)</bold> Growth status of <italic>P.mirabilis</italic> in 96-well plates after succinic acid treatment, showing (from top to bottom): control group, 5 mM, 10 mM, 15 mM, 20 mM, and 50 mM (A for MIC, B for MBIC). <bold>(C)</bold> MIC histogram. <bold>(D)</bold> MBIC histogram. The independent-samples t-test was used to compare the differences between each pair of groups for continuous data. * indicates P &lt; 0.05, ** indicates P &lt; 0.01, *** indicates P &lt; 0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1650340-g003.tif">
<alt-text content-type="machine-generated">Two panels show experiments with different concentrations of SA in wells. Panel A (left) shows clear wells labeled with control, 5mM, 10mM, 15mM, 20mM, and 50mM SA. Panel B (right) shows wells with a purple hue under the same labels. Panels C and D feature bar charts illustrating inhibition rates with SA concentrations, showing statistical significance with asterisks. Panel C uses red to orange colors, while Panel D uses shades of green.</alt-text>
</graphic>
</fig>
<p>For biofilm formation (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3D</bold>
</xref>), succinic acid exhibited concentration-dependent inhibition, with 15 mM demonstrating the most significant suppression (P &lt; 0.001). This concentration achieved &gt;50% biofilm inhibition, thereby being determined as the MBIC against <italic>P.mirabilis</italic>.</p>
</sec>
<sec id="s3_2">
<title>Metabolomics analysis</title>
<p>We performed metabolomic analysis on <italic>P.mirabilis</italic> treated with succinic acid. <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4D</bold>
</xref> illustrates the distribution of compounds across different metabolic pathways and biological processes, primarily encompassing metabolism, cellular processes, environmental information processing, genetic information processing, and human diseases. Among these, pathways related to amino acid metabolism, nucleotide metabolism, and membrane transport contained a higher number of compounds, whereas processes such as cellular motility and lipid metabolism exhibited fewer. <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4E</bold>
</xref> presents the KEGG pathway enrichment analysis of the metabolomics data. The differentially abundant metabolites were predominantly enriched in nucleotide metabolism, purine metabolism, and arginine biosynthesis, which are primarily associated with bacterial stress adaptation and metabolic regulatory mechanisms.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Metabolomic analysis of succinic acid&#x2019;s inhibition on <italic>P.mirabilis</italic>. <bold>(A)</bold> PCA analysis demonstrated good intra-group reproducibility and significant inter-group separation between the experimental group (MIC concentration of succinic acid treatment) and control group (untreated). <bold>(B)</bold> Volcano plot revealed 196 upregulated and 394 downregulated metabolites in the experimental group compared to controls. <bold>(C)</bold> Venn diagram showed 83 unique metabolites in controls, 31 in treated group, and 1630 shared metabolites. <bold>(D)</bold> Distribution of compounds across different metabolic pathways and biological processes. <bold>(E)</bold> KEGG pathway enrichment analysis.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1650340-g004.tif">
<alt-text content-type="machine-generated">Group of analytical charts including a PCA score plot identifying clusters of control, test, and QC samples; a volcano plot showing significant differences between test and control groups with highlighted gene expressions; a Venn diagram depicting overlapping data sets between test and control with shared and distinct elements; a bar chart summarizing pathway statistics for different metabolic activities; and a dot plot for KEGG enrichment analysis displaying rich factors and p-values for various metabolic pathways.</alt-text>
</graphic>
</fig>
<p>Among the various metabolic pathways, those related to amino acid metabolism were particularly critical, as their alterations were directly linked to the regulatory effects of D-amino acids (e.g., L-methionine, L-lysine, L-aspartic acid, linatine) and tryptophan on bacterial physiology. D-amino acids significantly inhibit bacterial growth and disrupt biofilm stability through multiple molecular mechanisms. First, at the protein synthesis level, D-amino acids induce tRNA misacylation and feedback inhibition of key metabolic pathways, leading to ribosomal dysfunction and translational errors. Second, D-amino acids directly interfere with peptidoglycan biosynthesis and are aberrantly incorporated into peptidoglycan side chains, resulting in defective cell wall cross-linking and reduced mechanical strength (<xref ref-type="bibr" rid="B30">Kuru et&#xa0;al., 2012</xref>). Collectively, these effects cause bacterial growth arrest and eventual lysis. Regarding biofilm regulation, D-amino acids function via a dual mechanism: at subinhibitory concentrations, they disrupt quorum sensing systems and downregulate the expression of genes encoding biofilm matrix components, such as extracellular polysaccharides and pilin proteins (<xref ref-type="bibr" rid="B33">Leiman et&#xa0;al., 2013</xref>); at higher concentrations, D-amino acids are specifically incorporated into mature biofilm structures, displacing D-alanine residues in peptidoglycan peptide bridges, thereby disrupting the anchoring connections between amyloid fibers and cell wall lipoproteins and leading to biofilm structural collapse (<xref ref-type="bibr" rid="B29">Kolodkin-Gal et&#xa0;al., 2010</xref>).</p>
<p>The tryptophan metabolic pathway plays a pivotal role in bacterial physiological regulation, with its metabolic network modulating genetic stability, virulence expression, and environmental adaptability through multi-layered molecular mechanisms. Metabolomic analysis revealed significant decreases in key tryptophan pathway intermediates, including indole pyruvate, indole acetate, and tryptamine (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;1</bold>
</xref>). Following enzymatic degradation by tryptophanase, tryptophan not only serves as a carbon/nitrogen source for bacteria but also generates indole pyruvate&#x2014;a critical nodal metabolite that participates in dynamic energy metabolism balance via transamination to produce indole acetate. The depletion of indole pyruvate directly impairs branched-chain amino acid biosynthesis, leading to dysregulated expression of drug resistance-associated proteins (<xref ref-type="bibr" rid="B2">Anyanful et&#xa0;al., 2005</xref>), while reduced indole acetate levels compromise its function in stimulating extracellular polysaccharide synthesis, thereby weakening biofilm matrix integrity (<xref ref-type="bibr" rid="B9">Bianco et&#xa0;al., 2006</xref>). This metabolic disturbance further extends to quorum sensing systems, where diminished tryptamine&#x2014;a decarboxylation product of tryptophan&#x2014;may disrupt neurotransmitter-mimicking mechanisms in bacterial communication (<xref ref-type="bibr" rid="B32">Lee et&#xa0;al., 2007</xref>).</p>
<p>The biosynthesis pathways of phenylalanine, tyrosine, and tryptophan occupy central positions in bacterial metabolic networks. By regulating the synthesis of these amino acids, bacteria finely tune intra- and extracellular metabolic homeostasis, influencing essential molecular transport processes, interpopulation signaling, and biofilm formation. Relevant studies demonstrate that these pathways are closely associated with bacterial EPS secretion, which directly governs collective behaviors, antibiotic resistance, and pathogenicity (<xref ref-type="bibr" rid="B23">Guill&#xed;n et&#xa0;al., 2025</xref>). Additionally, these amino acids participate in protein synthesis and energy metabolism. Inhibition or marked reduction of phenylalanine biosynthesis impairs bacterial acquisition and utilization of other essential amino acids, ultimately suppressing growth and proliferative capacity (<xref ref-type="bibr" rid="B64">Zhu et&#xa0;al., 2024</xref>).</p>
</sec>
<sec id="s3_3">
<title>Transcriptomics analysis</title>
<p>KEGG enrichment analysis revealed significant alterations in arginine biosynthesis, glutamine family amino acid metabolism, alanine/aspartate metabolism, nucleotide metabolism, ribosome biogenesis, and oxidative phosphorylation pathways (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref>). The heatmap displays the expression patterns of the top 30 DEGs between control and treatment groups (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5D</bold>
</xref>). Notably, <italic>artP</italic> and <italic>artJ</italic> genes comprising the arginine transport system cluster <italic>artPIQM-artJ</italic> were markedly upregulated in the succinic acid-treated group. <italic>artP</italic> encodes the ATP-binding protein ArtP of the arginine ABC transporter, which is crucial for transmembrane arginine transport. Given arginine&#x2019;s importance for bacterial acid resistance, <italic>P.mirabilis</italic> may employ ABC transporters to accumulate osmoprotectants, thereby mitigating osmotic stress by balancing transmembrane gradients (<xref ref-type="bibr" rid="B22">Grigg et&#xa0;al., 2010</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Proteomic analysis of <italic>P. mirabilis</italic> under succinic acid treatment revealed significant alterations in protein expression patterns. <bold>(A)</bold> PCA analysis and <bold>(B)</bold> Pearson correlation coefficients demonstrated high reproducibility among biological replicates. <bold>(C)</bold> Differential protein expression analysis identified 182 significantly upregulated and 252 downregulated proteins, <bold>(D)</bold> with biofilm formation-related pathways being particularly affected as shown in the volcano plot and <bold>(E)</bold> KEGG enrichment analysis. T represents the control group, and H represents the treated group.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1650340-g005.tif">
<alt-text content-type="machine-generated">Diagram showing four panels: A) Venn diagram with overlapping sets for CONTROL and TEST, indicating shared and unique elements; B) Volcano plot displaying gene expression fold changes with blue and red dots indicating downregulated and upregulated genes, respectively; C) KEGG enrichment analysis scatter plot showing the significance of various pathways, represented by dot size and color; D) Heatmap depicting gene expression levels, with a color gradient from red to blue denoting expression intensity.</alt-text>
</graphic>
</fig>
<p>Multiple genes associated with arginine biosynthesis (<italic>argA, argB, gdhA, argH, argE, argC, argF</italic>) and stress response (<italic>pmi_rs16385, pmi_rs04750, pmi_rs11330, pmi_rs06360</italic>) were significantly upregulated (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;2</bold>
</xref>), indicating activation of metabolic adaptation and stress response mechanisms following succinic acid treatment. Furthermore, <italic>argR</italic> - encoding the arginine repressor ArgR that negatively regulates arginine biosynthetic genes - showed pronounced upregulation. The <italic>argR</italic> regulon includes its own autoregulatory gene, the <italic>carAB</italic> operon, and genes involved in arginine transport and catabolism (<xref ref-type="bibr" rid="B15">Cho et&#xa0;al., 2015</xref>).</p>
<p>Genes encoding 30S and 50S ribosomal subunit proteins (<italic>rplR</italic>, <italic>rplP</italic>, <italic>rpsC</italic>, <italic>rpmI</italic>) were significantly enriched among downregulated genes (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;2</bold>
</xref>). Notably, <italic>infB</italic>&#x2014;which encodes translation initiation factor IF-2&#x2014;was also markedly downregulated. IF-2 facilitates GTP hydrolysis to GDP and inorganic phosphate (Pi), releasing initiation factors to enable 50S-30S ribosomal subunit association into the 70S initiation complex. The suppression of <italic>infB</italic> inhibits ribosomal biogenesis, thereby blocking protein synthesis and exerting bacteriostatic effects.</p>
<p>Major facilitator superfamily (MFS) transporter genes (<italic>pmi_rs14645, pmi_rs07650, pmi_rs04170, pmi_rs11915</italic>) were significantly downregulated in the succinic acid-treated group. As Gram-negative bacterial efflux pumps, MFS transporters mediate the extrusion of diverse substrates (ions, sugars, amino acids, drugs, and toxins), contributing to multidrug resistance (<xref ref-type="bibr" rid="B18">Du et&#xa0;al., 2018</xref>). Additionally, MFS transporters participate in biofilm maturation (<xref ref-type="bibr" rid="B41">May et&#xa0;al., 2009</xref>), osmostress protection, and bacterial motility. Prior studies confirm that disrupting MFS transporter genes reduces crystalline biofilm formation in <italic>P.mirabilis</italic> and increases antibiotic susceptibility (<xref ref-type="bibr" rid="B25">Holling et&#xa0;al., 2014</xref>).</p>
<p>The NADH:ubiquinone oxidoreductase (respiratory Complex I)&#x2014;a core enzyme in bacterial energy metabolism&#x2014;couples NADH oxidation with ubiquinone reduction to drive proton translocation for ATP synthesis. Succinic acid treatment significantly downregulated <italic>nuoI, nuoG, nuoH</italic>, and <italic>nuoJ</italic> (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;2</bold>
</xref>): <italic>nuoG</italic>: Stabilizes Complex I via its iron-sulfur cluster-binding sites; its absence causes NDH-1 assembly defects, preventing integration of peripheral subunits (except <italic>nuoC</italic> and <italic>nuoD</italic>) <italic>(</italic>
<xref ref-type="bibr" rid="B46">Pohl et&#xa0;al., 2007</xref>); <italic>nuoH</italic> and <italic>nuoJ</italic>: Form transmembrane domains housing the quinone-binding site and proton channels; their dysfunction impairs electron transport chain (ETC) efficiency (<xref ref-type="bibr" rid="B21">Friedrich et&#xa0;al., 2016</xref>); <italic>nuoI</italic>: A core subunit mediating electron transfer from the NADH dehydrogenase module to the membrane arm; its loss abolishes complex activity (<xref ref-type="bibr" rid="B24">Hedderich and Forzi, 2005</xref>). Furthermore, <italic>cyoE</italic>&#x2014;encoding heme O synthase&#x2014;was significantly downregulated. This enzyme catalyzes heme O biosynthesis, a critical component of bacterial terminal oxidases O (<xref ref-type="bibr" rid="B42">Mogi et&#xa0;al., 1994</xref>). The coordinated downregulation of these genes disrupts ETC electron transfer, proton pumping, and complex assembly, ultimately blocking ATP synthesis and inhibiting bacterial growth.</p>
</sec>
<sec id="s3_4">
<title>Proteomics analysis</title>
<p>Key components of the Type VI Secretion System (T6SS), including TssN, TssC, TssA, IdrA, TssJ, and TssH, were significantly downregulated (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;3</bold>
</xref>, <xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref>). The T6SS plays a crucial role in the pathogenesis of <italic>P.mirabilis</italic> by mediating self-recognition and territorial behaviors through interbacterial competition, as well as exerting an indirect influence on swarming motility via strain competition (<xref ref-type="bibr" rid="B48">Saak et&#xa0;al., 2017</xref>). Although its direct role in biofilm formation and stress response in <italic>P.mirabilis</italic> has not been fully elucidated, studies in other bacterial species suggest that T6SS may modulate these processes (<xref ref-type="bibr" rid="B62">Xiong et&#xa0;al., 2024</xref>). Specifically, TssA is essential for bacterial fitness during pyelonephritis, with <italic>tssA</italic> mutants showing impaired colonization in murine bladder infection models (<xref ref-type="bibr" rid="B17">Debnath et&#xa0;al., 2018</xref>). TssC and TssB form heterodimers that assemble into the contractile sheath required for T6SS function, while TssJ (ClpV) mediates ATP-dependent sheath disassembly and its deletion affects motility, biofilm formation, and EPS production (<xref ref-type="bibr" rid="B34">Li et&#xa0;al., 2024</xref>). TssN connects the membrane complex to the baseplate through interaction with TssK to facilitate effector translocation (<xref ref-type="bibr" rid="B11">Bongiovanni et&#xa0;al., 2024</xref>), and TssH is required for effector secretion and virulence, with mutants exhibiting defects in T6SS assembly and regulation (<xref ref-type="bibr" rid="B5">Asolkar and Ramesh, 2020</xref>).</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Proteomic analysis of <italic>P.mirabilis</italic> under succinic acid treatment revealed significant alterations in protein expression patterns. <bold>(A)</bold> PCA analysis and <bold>(B)</bold> Pearson correlation coefficients demonstrated high reproducibility among biological replicates. <bold>(C)</bold> Differential protein expression analysis identified 182 significantly upregulated and 252 downregulated proteins, <bold>(D)</bold> with biofilm formation-related pathways being particularly affected as shown in the volcano plot and <bold>(E)</bold> KEGG enrichment analysis.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1650340-g006.tif">
<alt-text content-type="machine-generated">Panel image with five subfigures depicting protein analysis data:  A: Principal component analysis (PCA) plot showing two distinct groups, T and H. B: Heatmap of Pearson correlation coefficients among samples T1, T2, T3, H1, H2, H3. C: Bar chart of protein regulation with 252 proteins upregulated and 182 downregulated. D: Volcano plot displaying log2 T/H ratio versus negative log10 P-value, highlighting regulated types (up, down, unchanged). E: Bubble chart demonstrating pathway enrichment analysis, with bubble size indicating protein number and color indicating P-value significance.</alt-text>
</graphic>
</fig>
<p>Proteomic analysis revealed that <italic>P.mirabilis</italic> requires three gene clusters (ids, tss, and idr) for self-recognition, with Ids and Idr proteins representing two distinct mechanisms. Ids proteins encode strain-specific identity determinants, while Idr proteins mediate inter-strain competition during population migration (<xref ref-type="bibr" rid="B48">Saak et&#xa0;al., 2017</xref>). T6SS is essential for secreting these proteins, enabling self-recognition and territorial behaviors. Through direct cell contact, T6SS delivers effectors into target cell periplasm via its contractile puncturing apparatus, inducing cell death (<xref ref-type="bibr" rid="B26">Hood et&#xa0;al., 2010</xref>). This contact-dependent delivery mechanism underlies its bactericidal function. Importantly, T6SS contributes to catheter-associated urinary tract infection progression (<xref ref-type="bibr" rid="B3">Armbruster et&#xa0;al., 2017</xref>), suggesting that succinic acid may inhibit biofilm formation by modulating T6SS-related protein secretion or function.</p>
<p>Additionally, the TCA cycle was significantly enriched in KEGG analysis, with key enzymes downregulated (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;3</bold>
</xref>, <xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref>). In <italic>Candida albicans</italic>, the TCA cycle is crucial for mature biofilm formation (<xref ref-type="bibr" rid="B51">Sun et&#xa0;al., 2022</xref>), influencing matrix synthesis/modification and structural stability. Disrupted TCA cycle enzymes increase dead cells and reduce biofilm biomass, indicating its role in maintaining metabolic homeostasis and biofilm integrity (<xref ref-type="bibr" rid="B16">De Backer et&#xa0;al., 2018</xref>). <italic>Bacillus subtilis</italic> studies show TCA intermediate accumulation during early biofilm formation (12&#x2013;16 hours) enhances metabolic activity, providing material/energy for growth. These intermediates correlate with extracellular matrix (ECM) synthesis, coinciding with upregulated ECM gene expression and biosynthetic precursor levels (<xref ref-type="bibr" rid="B45">Pisithkul et&#xa0;al., 2019</xref>), Proteomic analysis further demonstrated significant downregulation of the siderophore biosynthesis system, including key genes <italic>nrpS</italic> (nonribosomal peptide synthase) and <italic>nrpU</italic> (siderophore biosynthesis gene).This specific impairment of siderophore production will critically impair <italic>P.mirabilis</italic> pathogenicity and environmental adaptation (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;3</bold>
</xref>). The Nrp system maintains bacterial survival under iron-limited host conditions through competitive iron chelation and transport mediated by siderophores (<xref ref-type="bibr" rid="B4">Armbruster et&#xa0;al., 2018</xref>). Dysfunction of this biosynthetic system directly compromises iron acquisition capacity, leading to impaired virulence factor expression and disruption of critical pathogenic processes including swarming motility regulation and flagella synthesis. Mouse infection models confirmed the essential role of the Nrp system in host colonization, with mutants showing significantly reduced adherence in bladder and kidney tissues (<xref ref-type="bibr" rid="B49">Schaffer and Pearson, 2015</xref>). Furthermore, dysregulation of iron metabolism-related genes disrupts redox homeostasis, inhibits activation of iron acquisition systems under iron-restricted conditions, and weakens bacterial competition against host iron-binding proteins, ultimately impairing metabolic balance and environmental adaptability (<xref ref-type="bibr" rid="B39">Malik and Hedrich, 2021</xref>).</p>
</sec>
<sec id="s3_5">
<title>Exploration of therapeutic targets</title>
<p>Although the direct contribution of T6SS to biofilm formation in <italic>P.mirabilis</italic> is not yet definitive, our data suggest that succinic acid-induced downregulation of T6SS components may indirectly impair biofilm development by disrupting bacterial competition and microcolony architecture. Furthermore, the proposed deacetylation of H-NS and enhanced repression of T6SS genes represent a novel regulatory mechanism that could potentially influence a network of virulence factors, including those involved in biofilm formation.</p>
<p>The histone-like nucleoid structuring protein (H-NS) functions as a global transcriptional regulator that modulates bacterial environmental adaptation through selective silencing of virulence genes. In <italic>Edwardsiella</italic>, H-NS has been shown to repress T6SS gene expression by binding AT-rich promoter regions of T6SS gene clusters and forming transcriptional silencing complexes (<xref ref-type="bibr" rid="B37">Ma et&#xa0;al., 2022</xref>). The molecular activity of H-NS is determined by its domain architecture: the N-terminal oligomerization domain mediates self-assembly into functional dimers/tetramers, while the C-terminal DNA-binding domain specifically recognizes target gene promoters (<xref ref-type="bibr" rid="B10">Blot et&#xa0;al., 2006</xref>). Notably, the transcriptional repression activity of H-NS is highly dependent on its oligomeric state, as non-oligomerized monomers lack the cooperative binding capacity required for effective RNA polymerase inhibition (<xref ref-type="bibr" rid="B35">Liu et&#xa0;al., 2021</xref>). However, whether H-NS regulates T6SS genes through a similar mechanism in <italic>P.mirabilis</italic> remains unreported, presenting a key mechanistic avenue for investigation in this study.</p>
<p>Bacteria dynamically modulate H-NS function via post-translational modifications (PTMs) to adapt to environmental stress (<xref ref-type="bibr" rid="B38">Macek et&#xa0;al., 2019</xref>). While existing research on succinic acid&#x2019;s effects on bacterial phenotypes has primarily focused on succinylation (<xref ref-type="bibr" rid="B61">Wu et&#xa0;al., 2025</xref>), studies of H-NS PTMs have largely examined phosphorylation (<xref ref-type="bibr" rid="B35">Liu et&#xa0;al., 2021</xref>). Recently, acetylation modifications have emerged as a research focus in metabolite-epigenetic regulation due to their close coupling with central metabolism. Studies reveal that acetylation at K120 within the DNA-binding domain of H-NS abolishes its transcriptional repression activity (<xref ref-type="bibr" rid="B36">Liu et&#xa0;al., 2024</xref>). Nevertheless, the functional consequences of acetylation in the N-terminal oligomerization domain and its mechanistic links to metabolic signaling remain unexplored.</p>
<p>This study reveals for the first time that succinic acid specifically modulates the post-translational modification status of <italic>P.mirabilis</italic> H-NS. Acetylomic analysis demonstrated a significant decrease in &#x3f5;-amino acetylation at lysine 6 (K6) of H-NS in succinic acid-treated groups compared to controls (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table&#xa0;4</bold>
</xref>). Structural modeling (SWISS-MODEL, WP_368934229.1) and PyMOL annotation localized the K6 site within the N-terminal oligomerization domain of H-NS (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1A</bold>
</xref>). Functional enrichment analysis further indicated that differentially acetylated proteins were predominantly associated with protein complex oligomerization and tetramerization processes, suggesting succinic acid may influence H-NS function by coordinately regulating multiprotein complex assembly (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1B</bold>
</xref>).</p>
<p>Based on these findings, we propose a cascade regulation hypothesis: Succinic acid specifically reduces K6 acetylation of H-NS, inducing conformational rearrangement in its N-terminal oligomerization domain. This promotes the formation of highly stable H-NS tetramers with enhanced binding affinity for AT-rich promoter regions of T6SS gene clusters, thereby strengthening transcriptional repression of T6SS-related genes (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7</bold>
</xref>).</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>A proposed model illustrating how succinic acid-induced H-NS deacetylation may regulate T6SS to influence <italic>P.mirabilis</italic> biofilm formation on D-J stents. <bold>(A)</bold> Normal biofilm formation process in <italic>P.mirabilis</italic>: The H-NS protein at the K6 site exhibits normal acetylation and oligomerization levels, suppressing the transcription and expression of T6SS-related genes, ultimately leading to biofilm formation. <bold>(B)</bold> In <italic>P.mirabilis</italic> treated with succinate (compared to untreated), the H-NS protein at the K6 site shows reduced acetylation, leading to higher oligomerization, enhanced dimer/tetramer formation, and stronger transcriptional repression of T6SS-related genes. Consequently, fewer T6SS-related proteins are produced, ultimately reducing biofilm formation. It should be noted that biofilm formation is a complex, multifactorial process, and succinic acid may additionally influence this process through broader mechanisms.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1650340-g007.tif">
<alt-text content-type="machine-generated">Diagram showing two bacterial cells labeled A and B, illustrating differing processes inside each. Inset boxes display protein structures with C-terminal and N-terminal labels. Below, surfaces depict biofilm formation on D-J ureteral stent surfaces, with different molecular interactions including P. mirabilis, H-NS protein, and other components like acetyl groups and succinic acid. Legend identifies various elements such as T6SS DNA, mRNA, and proteins.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>This study employed focused metabolomics, transcriptomics, proteomics, and acetylomics to elucidate the inhibitory effects of succinate on <italic>P.mirabilis</italic>&#x2014;a key pathogen in CAUTIs&#x2014;and to identify core regulatory nodes under succinate stress. Through targeted multi-omics analyses, we reliably identified key drivers and demonstrated that succinate disrupts bacterial growth and biofilm formation by modulating central metabolic pathways, inhibiting transcription, and altering post-translational modifications. These findings provide novel insights into the molecular interplay between metabolic perturbation and bacterial pathogenicity regulation, offering potential strategies against drug-resistant pathogens.</p>
<p>Succinate exhibits multimodal antibacterial advantages, acting across metabolic, transcriptional, proteomic, and epigenetic regulatory layers to form a synergistic inhibitory network that significantly reduces resistance risks. Our metabolomics analysis revealed significant depletion of tryptophan pathway intermediates alongside global amino acid metabolic dysregulation. This aligns with transcriptomic data showing downregulation of ribosomal genes (<italic>rplR</italic>, <italic>rpsC</italic>) and ATP synthase subunits (<italic>atpD/G/H</italic>). As an essential amino acid, disrupted tryptophan metabolism may impair protein synthesis by limiting translation substrates, disrupting quorum sensing, or interfering with cofactor synthesis, collectively leading to translational arrest, energy imbalance, and compromised biofilm matrix stability.</p>
<p>Notably, succinate suppresses the tricarboxylic acid cycle and oxidative phosphorylation, markedly reducing metabolic flux. Proteomics data further indicate significant downregulation of virulence-associated T6SS core components and iron acquisition system proteins (<italic>NrpS</italic>, <italic>NrpU</italic>), suggesting that metabolic disruption weakens virulence factor production and iron homeostasis, jointly inhibiting biofilm formation. Acetylomics data reveal that succinate induces H-NS deacetylation at K6, potentially enhancing its oligomerization and binding affinity to AT-rich promoter regions of T6SS gene clusters, thereby reinforcing transcriptional repression. This finding links succinate-induced metabolic stress to H-NS-mediated epigenetic regulation.</p>
<p>Traditional antibiotics exert their effects by targeting a single mechanism, such as inhibiting cell wall synthesis (&#x3b2;-lactams), blocking DNA replication (quinolones), or interfering with translation (macrolides). However, this single-target strategy is prone to inducing resistance. In recent years, significant progress has been made in understanding bacterial antibiotic resistance mechanisms, which include the following specific pathways: 1. Enzymatic modification of antibiotics with chemical groups to prevent their binding to bacterial targets (<xref ref-type="bibr" rid="B60">Wright, 2005</xref>); 2. Downregulation of porins, reducing antibiotic uptake into cells (<xref ref-type="bibr" rid="B20">Fern&#xe1;ndez and Hancock, 2012</xref>); 3) Bacterial production of a new target protein that binds to the antibiotic (<xref ref-type="bibr" rid="B59">Wilson et&#xa0;al., 2020</xref>); 4. Increased expression of efflux pumps to expel antibiotics from bacterial cells (<xref ref-type="bibr" rid="B57">Webber and Piddock, 2003</xref>); 5. Protection of ribosomes through mechanisms such as antibiotic removal, enabling ribosomes to evade drug inhibition (<xref ref-type="bibr" rid="B54">Thaker et&#xa0;al., 2010</xref>). Our transcriptomics results demonstrate that succinate simultaneously downregulates the expression of ribosomal proteins and MFS proteins, effectively counteracting these bacterial antibiotic resistance mechanisms.</p>
<p>Compared to traditional antibiotics, succinate&#x2019;s multimodal mechanism offers distinct advantages. Unlike single-target drugs that readily induce resistance, succinate disrupts <italic>P.mirabilis</italic> through a synergistic multi-mechanism network. Fluoxetine and thioridazine, as efflux pump inhibitors, suppress <italic>P.mirabilis</italic> efflux activity, significantly reducing the rate of crystalline biofilm formation on catheters and markedly impairing <italic>P.mirabilis</italic> swimming and swarming motility (<xref ref-type="bibr" rid="B43">Nzakizwanayo et&#xa0;al., 2017</xref>). Current research indicates that adjuvants can effectively block antibiotic enzymatic degradation or promote intracellular accumulation, partially overcoming bacterial resistance (<xref ref-type="bibr" rid="B58">Williford et&#xa0;al., 2023</xref>). This multi-target intervention logic targeting bacterial core survival mechanisms is highly consistent with current cutting-edge antimicrobial strategies, providing important insights for addressing the challenge of antimicrobial resistance.</p>
<p>Specifically, interventions targeting bacteria&#x2019;s own essential physiological processes are more effective in preventing the emergence and development of antimicrobial resistance. Antibiotics conjugated with siderophores can exploit bacteria&#x2019;s inherent requirement for iron, enabling active uptake via specific outer membrane receptors. This not only bypasses &#x3b2;-lactamase degradation and outer membrane barriers but also ensures precise delivery of the antibiotics to their sites of action (<xref ref-type="bibr" rid="B55">Tillotson, 2016</xref>). Bacterial metallophore systems like siderophores and zincophores are critical targets for antimicrobial intervention. Interventions targeting these systems, whether by inhibiting their biosynthesis, blocking their secretion or disrupting their metal-binding capability, can perturb bacterial metal ion homeostasis. As a core foundation for bacterial survival and virulence, this disrupted homeostasis ultimately suppresses the colonization of drug-resistant strains (<xref ref-type="bibr" rid="B19">Ezzeddine and Ghssein, 2023</xref>). This aligns well with the mode of action of succinate: both approaches act by targeting bacterial &#x201c;essential physiological processes&#x201d; rather than &#x201c;single protein targets,&#x201d; essentially representing a systemic intervention on bacterial survival mechanisms.</p>
<p>Based on the decoded multimodal mechanism of succinate in this study, future exploration of combined strategies&#x2014;pairing succinate with adjuvants or antibiotics&#x2014;could not only reduce antibiotic efflux and enhance drug retention but also restore bacterial antibiotic susceptibility, achieving a triple antimicrobial effect: &#x201c;enzyme inhibition&#x2013;efflux blockade&#x2013;sensitivity restoration.&#x201d; This multi-target combinatorial approach may overcome the resistance limitations of traditional therapies, offering a more sustainable solution for drug-resistant infections. Amid the increasing emergence of super-resistant pathogens such as carbapenem-resistant Enterobacteriaceae and pan-drug-resistant strains, the application of succinic acid as an antimicrobial agent may represent a promising therapeutic strategy.</p>
<p>This study offers initial insights into the antibacterial mechanism of succinic acid, yet several limitations remain. The clinical tolerability and potential host cytotoxicity of the effective concentration have not been assessed, and biofilm analyses lack structural and compositional characterization. Moreover, the mono-omics approach limits comprehensive understanding of multi-level biological interactions. The proposed regulation of H-NS K6 deacetylation by succinic acid and its causal effect on T6SS require further validation via mutagenesis, ChIP-seq, and complementation assays. The potential influence of succinic acid on other post-translational modifications and their crosstalk with acetylation also remains unexplored. Finally, direct comparisons with standard antibiotics or other organic acids are needed to better contextualize its efficacy. These limitations highlight future directions, including systematic safety evaluation, integration of multi-omics and imaging technologies, mechanistic validation, and comparative efficacy studies to fully support its translational potential.</p>
</sec>
<sec id="s5" sec-type="conclusions">
<title>Conclusion</title>
<p>This study identifies succinate as a multifaceted inhibitor of <italic>P.mirabilis</italic> pathogenicity, acting through metabolic, transcriptional, and epigenetic pathways. By circumventing the resistance pitfalls of conventional single-target antibiotics, our findings provide a novel perspective for anti-biofilm therapeutic strategies. Future studies should refine succinate-based therapies or inspire the development of synthetic analogs targeting biofilm-associated infections.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The data presented in the study are as follows: the metabolomics data are deposited in the MetaboLights repository, accession number MTBLS12952; the transcriptomic data are deposited in the NCBI database, accession number PRJNA1320930; the proteomics and acetylomics data are deposited in the ProteomeXchange Consortium via the iProX partner repository, accession number PXD068166.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>AY: Formal Analysis, Writing &#x2013; original draft, Data curation, Conceptualization. YC: Writing &#x2013; original draft, Data curation, Formal Analysis, Conceptualization. ZZ: Conceptualization, Data curation, Formal Analysis, Writing &#x2013; original draft. YX: Writing &#x2013; original draft, Supervision, Methodology. CS: Methodology, Writing &#x2013; original draft, Supervision. WW: Validation, Supervision, Writing &#x2013; review &amp; editing. HY: Investigation, Writing &#x2013; original draft. SS: Writing &#x2013; review &amp; editing, Supervision, Validation. HL: Supervision, Writing &#x2013; review &amp; editing, Validation. XL: Supervision, Funding acquisition, Methodology, Writing &#x2013; original draft.</p>
</sec>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research and/or publication of this article. This work was supported by Applied Basic Research Program Project of Liaoning Province (Grant No. 2023JH2/101300124) and Liaoning Provincial Department of Education (Grant No. LJ222410161063).</p>
</sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s12" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcimb.2025.1650340/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcimb.2025.1650340/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alakomi</surname> <given-names>H. L.</given-names>
</name>
<name>
<surname>Skytt&#xe4;</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Saarela</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Mattila-Sandholm</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Latva-Kala</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Helander</surname> <given-names>I. M.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Lactic acid permeabilizes gram-negative bacteria by disrupting the outer membrane</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>66</volume>, <fpage>2001</fpage>&#x2013;<lpage>2005</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AEM.66.5.2001-2005.2000</pub-id>, PMID: <pub-id pub-id-type="pmid">10788373</pub-id></citation></ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anyanful</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Dolan-Livengood</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Lewis</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Sheth</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Dezalia</surname> <given-names>M. N.</given-names>
</name>
<name>
<surname>Sherman</surname> <given-names>M. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2005</year>). <article-title>Paralysis and killing of Caenorhabditis elegans by enteropathogenic Escherichia coli requires the bacterial tryptophanase gene</article-title>. <source>Mol. Microbiol.</source> <volume>57</volume>, <fpage>988</fpage>&#x2013;<lpage>1007</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-2958.2005.04739.x</pub-id>, PMID: <pub-id pub-id-type="pmid">16091039</pub-id></citation></ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Armbruster</surname> <given-names>C. E.</given-names>
</name>
<name>
<surname>Forsyth-DeOrnellas</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Johnson</surname> <given-names>A. O.</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>S. N.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>W.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Genome-wide transposon mutagenesis of Proteus mirabilis: Essential genes, fitness factors for catheter-associated urinary tract infection, and the impact of polymicrobial infection on fitness requirements</article-title>. <source>PloS pathogens</source> <volume>13</volume>, <elocation-id>e1006434</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1006434</pub-id>, PMID: <pub-id pub-id-type="pmid">28614382</pub-id></citation></ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Armbruster</surname> <given-names>C. E.</given-names>
</name>
<name>
<surname>Mobley</surname> <given-names>H. L. T.</given-names>
</name>
<name>
<surname>Pearson</surname> <given-names>M. M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Pathogenesis of proteus mirabilis infection</article-title>. <source>EcoSal Plus</source> <volume>8</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/ecosalplus.esp-0009-2017</pub-id>, PMID: <pub-id pub-id-type="pmid">29424333</pub-id></citation></ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asolkar</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Ramesh</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The involvement of the Type Six Secretion System (T6SS) in the virulence of Ralstonia solanacearum on brinjal</article-title>. <source>3 Biotech</source> <volume>10</volume>, <fpage>324</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s13205-020-02311-4</pub-id>, PMID: <pub-id pub-id-type="pmid">32656057</pub-id></citation></ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Awonusi</surname> <given-names>B. O.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>
<italic>In vitro</italic> and <italic>in vivo</italic> studies on bacteria and encrustation resistance of heparin/poly-L-lysine-Cu nanoparticles coating mediated by PDA for ureteral stent application</article-title>. <source>Regenerative biomaterials</source> <volume>9</volume>, <fpage>rbac047</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/rb/rbac047</pub-id>, PMID: <pub-id pub-id-type="pmid">35928999</pub-id></citation></ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bassetti</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Giacobbe</surname> <given-names>D. R.</given-names>
</name>
<name>
<surname>Vena</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Poulakou</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Rossolini</surname> <given-names>G. M.</given-names>
</name>
<name>
<surname>Soriano</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2025</year>). <article-title>Meropenem-vaborbactam for treatment of carbapenem-resistant enterobacterales: A narrative review of clinical practice evidence</article-title>. <source>Infect. Dis. Ther.</source> <volume>14</volume> (<issue>5</issue>), <fpage>973</fpage>&#x2013;<lpage>989</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s40121-025-01146-x</pub-id>, PMID: <pub-id pub-id-type="pmid">40216659</pub-id></citation></ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bedeni&#x107;</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Pospi&#x161;il</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Na&#x111;</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Bandi&#x107; Pavlovi&#x107;</surname> <given-names>D.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>Evolution of &#x3b2;-lactam antibiotic resistance in proteus species: from extended-spectrum and plasmid-mediated ampC &#x3b2;-lactamases to carbapenemases</article-title>. <source>Microorganisms.</source> <volume>13</volume> (<issue>3</issue>), <elocation-id>508</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/microorganisms13030508</pub-id>, PMID: <pub-id pub-id-type="pmid">40142401</pub-id></citation></ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bianco</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Imperlini</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Calogero</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Senatore</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Amoresano</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Carpentieri</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2006</year>). <article-title>Indole-3-acetic acid improves Escherichia coli's defences to stress</article-title>. <source>Arch. Microbiol.</source> <volume>185</volume>, <fpage>373</fpage>&#x2013;<lpage>382</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00203-006-0103-y</pub-id>, PMID: <pub-id pub-id-type="pmid">16555073</pub-id></citation></ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blot</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Mavathur</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Geertz</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Travers</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Muskhelishvili</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Homeostatic regulation of supercoiling sensitivity coordinates transcription of the bacterial genome</article-title>. <source>EMBO Rep.</source> <volume>7</volume>, <fpage>710</fpage>&#x2013;<lpage>715</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/sj.embor.7400729</pub-id>, PMID: <pub-id pub-id-type="pmid">16799466</pub-id></citation></ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bongiovanni</surname> <given-names>T. R.</given-names>
</name>
<name>
<surname>Latario</surname> <given-names>C. J.</given-names>
</name>
<name>
<surname>Le Cras</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Trus</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Robitaille</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Swartz</surname> <given-names>K.</given-names>
</name>
<etal/>
</person-group>. (<year>2024</year>). <article-title>Assembly of a unique membrane complex in type VI secretion systems of Bacteroidota</article-title>. <source>Nat. Commun.</source> <volume>15</volume>, <fpage>429</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-023-44426-1</pub-id>, PMID: <pub-id pub-id-type="pmid">38200008</pub-id></citation></ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caldara</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Bolhuis</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Marmiroli</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Marmiroli</surname> <given-names>N.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>Biofilm formation, modulation, and transcriptomic regulation under stress conditions in halomicronema sp</article-title>. <source>Int. J. Mol. Sci.</source> <volume>26</volume> (<issue>2</issue>), <elocation-id>673</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms26020673</pub-id>, PMID: <pub-id pub-id-type="pmid">39859390</pub-id></citation></ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chakkour</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Hammoud</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Farhat</surname> <given-names>S.</given-names>
</name>
<name>
<surname>El Roz</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Ezzeddine</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Ghssein</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Overview of Proteus mirabilis pathogenicity and virulence. Insights into the role of metals</article-title>. <source>Front. Microbiol.</source> <volume>15</volume>, <elocation-id>1383618</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2024.1383618</pub-id>, PMID: <pub-id pub-id-type="pmid">38646633</pub-id></citation></ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>Y. D.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>X. Y.</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>R. N.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Multiple inhibitory effects of succinic acid on Microcystis aeruginosa: morphology, metabolomics, and gene expression</article-title>. <source>Environ. technology</source> <volume>43</volume>, <fpage>3121</fpage>&#x2013;<lpage>3130</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/09593330.2021.1916090</pub-id>, PMID: <pub-id pub-id-type="pmid">33843481</pub-id></citation></ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cho</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Cho</surname> <given-names>Y. B.</given-names>
</name>
<name>
<surname>Kang</surname> <given-names>T. J.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>S. C.</given-names>
</name>
<name>
<surname>Palsson</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Cho</surname> <given-names>B. K.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>The architecture of ArgR-DNA complexes at the genome-scale in Escherichia coli</article-title>. <source>Nucleic Acids Res.</source> <volume>43</volume>, <fpage>3079</fpage>&#x2013;<lpage>3088</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkv150</pub-id>, PMID: <pub-id pub-id-type="pmid">25735747</pub-id></citation></ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Backer</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Sabirova</surname> <given-names>J.</given-names>
</name>
<name>
<surname>De Pauw</surname> <given-names>I.</given-names>
</name>
<name>
<surname>De Greve</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Hernalsteens</surname> <given-names>J. P.</given-names>
</name>
<name>
<surname>Goossens</surname> <given-names>H.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Enzymes catalyzing the TCA- and urea cycle influence the matrix composition of biofilms formed by methicillin-resistant staphylococcus aureus USA300</article-title>. <source>Microorganisms</source> <volume>6</volume> (<issue>4</issue>), <elocation-id>113</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/microorganisms6040113</pub-id>, PMID: <pub-id pub-id-type="pmid">30380651</pub-id></citation></ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Debnath</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Stringer</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>S. N.</given-names>
</name>
<name>
<surname>Bae</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Mobley</surname> <given-names>H. L. T.</given-names>
</name>
<name>
<surname>Wade</surname> <given-names>J. T.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>MrpJ Directly Regulates Proteus mirabilis Virulence Factors, Including Fimbriae and Type VI Secretion, during Urinary Tract Infection</article-title>. <source>Infection Immun.</source> <volume>86</volume> (<issue>10</issue>), <elocation-id>10.1128/iai.00388-18</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.00388-18</pub-id>, PMID: <pub-id pub-id-type="pmid">30082479</pub-id></citation></ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Wang-Kan</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Neuberger</surname> <given-names>A.</given-names>
</name>
<name>
<surname>van Veen</surname> <given-names>H. W.</given-names>
</name>
<name>
<surname>Pos</surname> <given-names>K. M.</given-names>
</name>
<name>
<surname>Piddock</surname> <given-names>L. J. V.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Multidrug efflux pumps: structure, function and regulation</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>16</volume>, <fpage>523</fpage>&#x2013;<lpage>539</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41579-018-0048-6</pub-id>, PMID: <pub-id pub-id-type="pmid">30002505</pub-id></citation></ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ezzeddine</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Ghssein</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Towards new antibiotics classes targeting bacterial metallophores</article-title>. <source>Microbial pathogenesis</source> <volume>182</volume>, <fpage>106221</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.micpath.2023.106221</pub-id>, PMID: <pub-id pub-id-type="pmid">37391099</pub-id></citation></ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fern&#xe1;ndez</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Hancock</surname> <given-names>R. E.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>25</volume>, <fpage>661</fpage>&#x2013;<lpage>681</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/CMR.00043-12</pub-id>, PMID: <pub-id pub-id-type="pmid">23034325</pub-id></citation></ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Friedrich</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Dekovic</surname> <given-names>D. K.</given-names>
</name>
<name>
<surname>Burschel</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Assembly of the Escherichia coli NADH:ubiquinone oxidoreductase (respiratory complex I)</article-title>. <source>Biochim. Biophys. Acta</source> <volume>1857</volume>, <fpage>214</fpage>&#x2013;<lpage>223</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbabio.2015.12.004</pub-id>, PMID: <pub-id pub-id-type="pmid">26682761</pub-id></citation></ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grigg</surname> <given-names>J. C.</given-names>
</name>
<name>
<surname>Cheung</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Heinrichs</surname> <given-names>D. E.</given-names>
</name>
<name>
<surname>Murphy</surname> <given-names>M. E.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Specificity of Staphyloferrin B recognition by the SirA receptor from Staphylococcus aureus</article-title>. <source>J. Biol. Chem.</source> <volume>285</volume>, <fpage>34579</fpage>&#x2013;<lpage>34588</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M110.172924</pub-id>, PMID: <pub-id pub-id-type="pmid">20810662</pub-id></citation></ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guill&#xed;n</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Ortiz</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Hidalgo</surname> <given-names>W.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>Comparative metabolic study of planktonic and sessile cells in Salmonella Enteritidis ATCC 13076: Elucidating metabolic pathways driving biofilm formation</article-title>. <source>PloS One</source> <volume>20</volume>, <elocation-id>e0317420</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0317420</pub-id>, PMID: <pub-id pub-id-type="pmid">39854347</pub-id></citation></ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hedderich</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Forzi</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Energy-converting [NiFe] hydrogenases: more than just H2 activation</article-title>. <source>J. Mol. Microbiol. Biotechnol.</source> <volume>10</volume> (<issue>2-4</issue>), <fpage>92</fpage>&#x2013;<lpage>104</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1159/000091557</pub-id>, PMID: <pub-id pub-id-type="pmid">16645307</pub-id></citation></ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holling</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Lednor</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Tsang</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Bissell</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Campbell</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Nzakizwanayo</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Elucidating the genetic basis of crystalline biofilm formation in Proteus mirabilis</article-title>. <source>Infection immunity</source> <volume>82</volume>, <fpage>1616</fpage>&#x2013;<lpage>1626</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.01652-13</pub-id>, PMID: <pub-id pub-id-type="pmid">24470471</pub-id></citation></ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hood</surname> <given-names>R. D.</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Hsu</surname> <given-names>F.</given-names>
</name>
<name>
<surname>G&#xfc;vener</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Carl</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Trinidad</surname> <given-names>R. R.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>A type VI secretion system of Pseudomonas aeruginosa targets a toxin to bacteria</article-title>. <source>Cell Host Microbe</source> <volume>7</volume>, <fpage>25</fpage>&#x2013;<lpage>37</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.chom.2009.12.007</pub-id>, PMID: <pub-id pub-id-type="pmid">20114026</pub-id></citation></ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hunt</surname> <given-names>B. C.</given-names>
</name>
<name>
<surname>Brix</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Vath</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Guterman</surname> <given-names>L. B.</given-names>
</name>
<name>
<surname>Taddei</surname> <given-names>S. M.</given-names>
</name>
<name>
<surname>Deka</surname> <given-names>N.</given-names>
</name>
<etal/>
</person-group>. (<year>2024</year>). <article-title>Metabolic interplay between Proteus mirabilis and Enterococcus faecalis facilitates polymicrobial biofilm formation and invasive disease</article-title>. <source>mBio.</source> <volume>15</volume>, <elocation-id>e0216424</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mbio.02164-24</pub-id>, PMID: <pub-id pub-id-type="pmid">39475232</pub-id></citation></ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacobsen</surname> <given-names>S. M.</given-names>
</name>
<name>
<surname>Shirtliff</surname> <given-names>M. E.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Proteus mirabilis biofilms and catheter-associated urinary tract infections</article-title>. <source>Virulence.</source> <volume>2</volume>, <fpage>460</fpage>&#x2013;<lpage>465</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4161/viru.2.5.17783</pub-id>, PMID: <pub-id pub-id-type="pmid">21921687</pub-id></citation></ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kolodkin-Gal</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Romero</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Clardy</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Kolter</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Losick</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>D-amino acids trigger biofilm disassembly</article-title>. <source>Sci (New York NY)</source> <volume>328</volume>, <fpage>627</fpage>&#x2013;<lpage>629</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.1188628</pub-id>, PMID: <pub-id pub-id-type="pmid">20431016</pub-id></citation></ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuru</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Hughes</surname> <given-names>H. V.</given-names>
</name>
<name>
<surname>Brown</surname> <given-names>P. J.</given-names>
</name>
<name>
<surname>Hall</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Tekkam</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Cava</surname> <given-names>F.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>
<italic>In Situ</italic> probing of newly synthesized peptidoglycan in live bacteria with fluorescent D-amino acids</article-title>. <source>Angewandte Chemie (International ed English)</source> <volume>51</volume>, <fpage>12519</fpage>&#x2013;<lpage>12523</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/anie.201206749</pub-id>, PMID: <pub-id pub-id-type="pmid">23055266</pub-id></citation></ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lebeaux</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Ghigo</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Beloin</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics</article-title>. <source>Microbiol. Mol. Biol. reviews: MMBR</source> <volume>78</volume>, <fpage>510</fpage>&#x2013;<lpage>543</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/MMBR.00013-14</pub-id>, PMID: <pub-id pub-id-type="pmid">25184564</pub-id></citation></ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Bansal</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Jayaraman</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Bentley</surname> <given-names>W. E.</given-names>
</name>
<name>
<surname>Wood</surname> <given-names>T. K.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Enterohemorrhagic Escherichia coli biofilms are inhibited by 7-hydroxyindole and stimulated by isatin</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>73</volume>, <fpage>4100</fpage>&#x2013;<lpage>4109</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AEM.00360-07</pub-id>, PMID: <pub-id pub-id-type="pmid">17483266</pub-id></citation></ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leiman</surname> <given-names>S. A.</given-names>
</name>
<name>
<surname>May</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Lebar</surname> <given-names>M. D.</given-names>
</name>
<name>
<surname>Kahne</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Kolter</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Losick</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>D-amino acids indirectly inhibit biofilm formation in Bacillus subtilis by interfering with protein synthesis</article-title>. <source>J. bacteriology</source> <volume>195</volume>, <fpage>5391</fpage>&#x2013;<lpage>5395</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JB.00975-13</pub-id>, PMID: <pub-id pub-id-type="pmid">24097941</pub-id></citation></ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Cong</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Dai</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>W.</given-names>
</name>
<etal/>
</person-group>. (<year>2024</year>). <article-title>The Role of ClpV in the Physiology and Pathogenicity of Xanthomonas citri subsp. citri Strain zlm1908</article-title>. <source>Microorganisms</source> <volume>12</volume> (<issue>12</issue>), <elocation-id>2536</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/microorganisms12122536</pub-id>, PMID: <pub-id pub-id-type="pmid">39770739</pub-id></citation></ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Xenogeneic silencing relies on temperature-dependent phosphorylation of the host H-NS protein in Shewanella</article-title>. <source>Nucleic Acids Res.</source> <volume>49</volume>, <fpage>3427</fpage>&#x2013;<lpage>3440</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkab137</pub-id>, PMID: <pub-id pub-id-type="pmid">33693785</pub-id></citation></ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Bu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Qin</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Shao</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2024</year>). <article-title>Lysine acetylation regulates the AT-rich DNA possession ability of H-NS</article-title>. <source>Nucleic Acids Res.</source> <volume>52</volume>, <fpage>1645</fpage>&#x2013;<lpage>1660</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkad1172</pub-id>, PMID: <pub-id pub-id-type="pmid">38059366</pub-id></citation></ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Gan</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Qiao</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Xenogeneic nucleoid-associated EnrR thwarts H-NS silencing of bacterial virulence with unique DNA binding</article-title>. <source>Nucleic Acids Res.</source> <volume>50</volume>, <fpage>3777</fpage>&#x2013;<lpage>3798</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkac180</pub-id>, PMID: <pub-id pub-id-type="pmid">35325196</pub-id></citation></ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macek</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Forchhammer</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Hardouin</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Weber-Ban</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Grangeasse</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Mijakovic</surname> <given-names>I.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Protein post-translational modifications in bacteria</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>17</volume>, <fpage>651</fpage>&#x2013;<lpage>664</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41579-019-0243-0</pub-id>, PMID: <pub-id pub-id-type="pmid">31485032</pub-id></citation></ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malik</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Hedrich</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Ferric iron reduction in extreme acidophiles</article-title>. <source>Front. Microbiol.</source> <volume>12</volume>, <elocation-id>818414</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2021.818414</pub-id>, PMID: <pub-id pub-id-type="pmid">35095822</pub-id></citation></ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manoharan</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Das</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Whiteley</surname> <given-names>G. S.</given-names>
</name>
<name>
<surname>Glasbey</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Kriel</surname> <given-names>F. H.</given-names>
</name>
<name>
<surname>Manos</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The effect of N-acetylcysteine in a combined antibiofilm treatment against antibiotic-resistant Staphylococcus aureus</article-title>. <source>J. antimicrobial chemotherapy</source> <volume>75</volume>, <fpage>1787</fpage>&#x2013;<lpage>1798</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jac/dkaa093</pub-id>, PMID: <pub-id pub-id-type="pmid">32363384</pub-id></citation></ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>May</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Ito</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Okabe</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Induction of multidrug resistance mechanism in Escherichia coli biofilms by interplay between tetracycline and ampicillin resistance genes</article-title>. <source>Antimicrobial Agents chemotherapy</source> <volume>53</volume>, <fpage>4628</fpage>&#x2013;<lpage>4639</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AAC.00454-09</pub-id>, PMID: <pub-id pub-id-type="pmid">19721076</pub-id></citation></ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mogi</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Saiki</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Anraku</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>Biosynthesis and functional role of haem O and haem A</article-title>. <source>Mol. Microbiol.</source> <volume>14</volume>, <fpage>391</fpage>&#x2013;<lpage>398</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-2958.1994.tb02174.x</pub-id>, PMID: <pub-id pub-id-type="pmid">7885224</pub-id></citation></ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nzakizwanayo</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Scavone</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Jamshidi</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Hawthorne</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Pelling</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Dedi</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Fluoxetine and thioridazine inhibit efflux and attenuate crystalline biofilm formation by Proteus mirabilis</article-title>. <source>Sci. Rep.</source> <volume>7</volume>, <fpage>12222</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-017-12445-w</pub-id>, PMID: <pub-id pub-id-type="pmid">28939900</pub-id></citation></ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patel</surname> <given-names>G. B.</given-names>
</name>
<name>
<surname>Rakholiya</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Shindhal</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Varjani</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Tabhani</surname> <given-names>N. M.</given-names>
</name>
<name>
<surname>Shah</surname> <given-names>K. R.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Lipolytic Nocardiopsis for reduction of pollution load in textile industry effluent and SWISS model for structural study of lipase</article-title>. <source>Bioresource technology</source> <volume>341</volume>, <fpage>125673</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biortech.2021.125673</pub-id>, PMID: <pub-id pub-id-type="pmid">34493419</pub-id></citation></ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pisithkul</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Schroeder</surname> <given-names>J. W.</given-names>
</name>
<name>
<surname>Trujillo</surname> <given-names>E. A.</given-names>
</name>
<name>
<surname>Yeesin</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Stevenson</surname> <given-names>D. M.</given-names>
</name>
<name>
<surname>Chaiamarit</surname> <given-names>T.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Metabolic Remodeling during Biofilm Development of Bacillus subtilis</article-title>. <source>mBio</source> <volume>10</volume> (<issue>3</issue>), <elocation-id>10.1128/mbio.00623-19</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mBio.00623-19</pub-id>, PMID: <pub-id pub-id-type="pmid">31113899</pub-id></citation></ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pohl</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Bauer</surname> <given-names>T.</given-names>
</name>
<name>
<surname>D&#xf6;rner</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Stolpe</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Sell</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Zocher</surname> <given-names>G.</given-names>
</name>
<etal/>
</person-group>. (<year>2007</year>). <article-title>Iron-sulfur cluster N7 of the NADH:ubiquinone oxidoreductase (complex I) is essential for stability but not involved in electron transfer</article-title>. <source>Biochemistry.</source> <volume>46</volume>, <fpage>6588</fpage>&#x2013;<lpage>6596</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/bi700371c</pub-id>, PMID: <pub-id pub-id-type="pmid">17489563</pub-id></citation></ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prywer</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Torzewska</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Cichomski</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Micha&#x142;owski</surname> <given-names>P. P.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Insights into the physical and chemical properties of struvite crystal surfaces in terms of the effectiveness of bacterial adhesion</article-title>. <source>Sci. Rep.</source> <volume>13</volume>, <fpage>5557</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-023-32758-3</pub-id>, PMID: <pub-id pub-id-type="pmid">37020117</pub-id></citation></ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saak</surname> <given-names>C. C.</given-names>
</name>
<name>
<surname>Zepeda-Rivera</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Gibbs</surname> <given-names>K. A.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>A single point mutation in a TssB/VipA homolog disrupts sheath formation in the type VI secretion system of Proteus mirabilis</article-title>. <source>PloS One</source> <volume>12</volume>, <elocation-id>e0184797</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0184797</pub-id>, PMID: <pub-id pub-id-type="pmid">28949977</pub-id></citation></ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schaffer</surname> <given-names>J. N.</given-names>
</name>
<name>
<surname>Pearson</surname> <given-names>M. M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Proteus mirabilis and urinary tract infections</article-title>. <source>Microbiol. Spectr.</source> <volume>3</volume> (<issue>5</issue>), <elocation-id>10.1128/microbiolspec.uti-0017-2013</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/microbiolspec.UTI-0017-2013</pub-id>, PMID: <pub-id pub-id-type="pmid">26542036</pub-id></citation></ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sokhn</surname> <given-names>E. S.</given-names>
</name>
<name>
<surname>Salami</surname> <given-names>A.</given-names>
</name>
<name>
<surname>El Roz</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Salloum</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Bahmad</surname> <given-names>H. F.</given-names>
</name>
<name>
<surname>Ghssein</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Antimicrobial Susceptibilities and Laboratory Profiles of Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis Isolates as Agents of Urinary Tract Infection in Lebanon: Paving the Way for Better Diagnostics</article-title>. <source>Med. Sci. (Basel Switzerland)</source> <volume>8</volume> (<issue>3</issue>), <elocation-id>32</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/medsci8030032</pub-id>, PMID: <pub-id pub-id-type="pmid">32823619</pub-id></citation></ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Jiao</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>The Antimicrobial Peptide AMP-17 Derived from Musca domestica Inhibits Biofilm Formation and Eradicates Mature Biofilm in Candida albicans</article-title>. <source>Antibiotics (Basel Switzerland)</source> <volume>11</volume> (<issue>11</issue>), <elocation-id>1474</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/antibiotics11111474</pub-id>, PMID: <pub-id pub-id-type="pmid">36358129</pub-id></citation></ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szczerbiec</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Piechocka</surname> <given-names>J.</given-names>
</name>
<name>
<surname>G&#x142;owacki</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Torzewska</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Organic Acids Secreted by Lactobacillus spp. Isolated from Urine and Their Antimicrobial Activity against Uropathogenic Proteus mirabilis</article-title>. <source>Molecules (Basel Switzerland)</source> <volume>27</volume> (<issue>17</issue>), <elocation-id>5557</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules27175557</pub-id>, PMID: <pub-id pub-id-type="pmid">36080323</pub-id></citation></ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szczerbiec</surname> <given-names>D.</given-names>
</name>
<name>
<surname>S&#x142;aba</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Torzewska</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Substances Secreted by Lactobacillus spp. from the Urinary Tract Microbiota Play a Protective Role against Proteus mirabilis Infections and Their Complications</article-title>. <source>Int. J. Mol. Sci.</source> <volume>25</volume> (<issue>1</issue>), <elocation-id>103</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms25010103</pub-id>, PMID: <pub-id pub-id-type="pmid">38203274</pub-id></citation></ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thaker</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Spanogiannopoulos</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Wright</surname> <given-names>G. D.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>The tetracycline resistome</article-title>. <source>Cell. Mol. Life sciences: CMLS</source> <volume>67</volume>, <fpage>419</fpage>&#x2013;<lpage>431</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00018-009-0172-6</pub-id>, PMID: <pub-id pub-id-type="pmid">19862477</pub-id></citation></ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tillotson</surname> <given-names>G. S.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Trojan horse antibiotics-A novel way to circumvent gram-negative bacterial resistance</article-title>? <source>Infect. Dis. (Auckl)</source> <volume>9</volume>, <fpage>45</fpage>&#x2013;<lpage>52</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4137/idrt.S31567</pub-id>, PMID: <pub-id pub-id-type="pmid">27773991</pub-id></citation></ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Ren</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Ji</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>Z.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>A modified biodegradable mesh ureteral stent for treating ureteral stricture disease</article-title>. <source>Acta biomaterialia</source> <volume>155</volume>, <fpage>347</fpage>&#x2013;<lpage>358</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.actbio.2022.11.022</pub-id>, PMID: <pub-id pub-id-type="pmid">36402295</pub-id></citation></ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Webber</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Piddock</surname> <given-names>L. J.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>The importance of efflux pumps in bacterial antibiotic resistance</article-title>. <source>J. antimicrobial chemotherapy</source> <volume>51</volume>, <fpage>9</fpage>&#x2013;<lpage>11</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jac/dkg050</pub-id>, PMID: <pub-id pub-id-type="pmid">12493781</pub-id></citation></ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williford</surname> <given-names>E. E.</given-names>
</name>
<name>
<surname>DeAngelo</surname> <given-names>C. M.</given-names>
</name>
<name>
<surname>Blake</surname> <given-names>K. S.</given-names>
</name>
<name>
<surname>Kumar</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Lam</surname> <given-names>K. K.</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>K. V.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>Structure-based design of bisubstrate tetracycline destructase inhibitors that block flavin redox cycling</article-title>. <source>J. medicinal Chem.</source> <volume>66</volume>, <fpage>3917</fpage>&#x2013;<lpage>3933</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/acs.jmedchem.2c01629</pub-id>, PMID: <pub-id pub-id-type="pmid">36877173</pub-id></citation></ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilson</surname> <given-names>D. N.</given-names>
</name>
<name>
<surname>Hauryliuk</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Atkinson</surname> <given-names>G. C.</given-names>
</name>
<name>
<surname>O'Neill</surname> <given-names>A. J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Target protection as a key antibiotic resistance mechanism</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>18</volume>, <fpage>637</fpage>&#x2013;<lpage>648</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41579-020-0386-z</pub-id>, PMID: <pub-id pub-id-type="pmid">32587401</pub-id></citation></ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wright</surname> <given-names>G. D.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Bacterial resistance to antibiotics: enzymatic degradation and modification</article-title>. <source>Advanced Drug delivery Rev.</source> <volume>57</volume>, <fpage>1451</fpage>&#x2013;<lpage>1470</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.addr.2005.04.002</pub-id>, PMID: <pub-id pub-id-type="pmid">15950313</pub-id></citation></ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Pang</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2025</year>). <article-title>Succinic acid synthesis regulated by succinyl-coenzyme A ligase (SUCLA) plays an important role in root response to alkaline salt stress in Leymus chinensis</article-title>. <source>Plant Physiol. biochemistry: PPB</source> <volume>220</volume>, <fpage>109485</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.plaphy.2025.109485</pub-id>, PMID: <pub-id pub-id-type="pmid">39787813</pub-id></citation></ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiong</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Wan</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Ding</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Cai</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>W.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Type VI secretion system drives bacterial diversity and functions in multispecies biofilms</article-title>. <source>Microbiological Res.</source> <volume>279</volume>, <fpage>127570</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.micres.2023.127570</pub-id>, PMID: <pub-id pub-id-type="pmid">38096690</pub-id></citation></ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Unveiling the hidden arsenal: new insights into Proteus mirabilis virulence in UTIs</article-title>. <source>Front. Cell. infection Microbiol.</source> <volume>14</volume>, <elocation-id>1465460</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2024.1465460</pub-id>, PMID: <pub-id pub-id-type="pmid">39606746</pub-id></citation></ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Metabolic profiles and microbial synergy mechanism of anammox biomass enrichment and membrane fouling alleviation in the anammox dynamic membrane bioreactor</article-title>. <source>Environ. Sci technology</source> <volume>58</volume>, <fpage>6284</fpage>&#x2013;<lpage>6295</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/acs.est.3c10030</pub-id>, PMID: <pub-id pub-id-type="pmid">38488464</pub-id></citation></ref>
</ref-list>
</back>
</article>